NXTC - NextCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5352.53M
Enterprise Value 3394.43M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)259.79
Price/Book (mrq)N/A
Enterprise Value/Revenue 3290.67
Enterprise Value/EBITDA 6-17.05

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,842.45%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.36M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.14M
Net Income Avi to Common (ttm)-23.96M
Diluted EPS (ttm)-2.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.55M
Total Cash Per Share (mrq)5.53
Total Debt (mrq)5M
Total Debt/Equity (mrq)4.57
Current Ratio (mrq)12.77
Book Value Per Share (mrq)-38.21

Cash Flow Statement

Operating Cash Flow (ttm)5.71M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 34.42%
52 Week High 322.75
52 Week Low 313.93
50-Day Moving Average 318.16
200-Day Moving Average 318.16

Share Statistics

Avg Vol (3 month) 3145.4k
Avg Vol (10 day) 3103.55k
Shares Outstanding 522.71M
Float 12.66M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (May 31, 2019) 41.79k
Short Ratio (May 31, 2019) 40.13
Short % of Float (May 31, 2019) 40.15%
Short % of Shares Outstanding (May 31, 2019) 40.11%
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A